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Abstract
Background: Snake venoms have signiﬁcant impacts on human populations through the morbidity and mortality
associated with snakebites and as sources of drugs, drug leads, and physiological research tools. Genes expressed by
venom-gland tissue, including those encoding toxic proteins, have therefore been sequenced but only with relatively
sparse coverage resulting from the low-throughput sequencing approaches available. High-throughput approaches
based on 454 pyrosequencing have recently been applied to the study of snake venoms to give the most complete
characterizations to date of the genes expressed in active venom glands, but such approaches are costly and still
provide a far-from-complete characterization of the genes expressed during venom production.
Results: We describe the de novo assembly and analysis of the venom-gland transcriptome of an eastern
diamondback rattlesnake (Crotalus adamanteus) based on 95,643,958 pairs of quality-ﬁltered, 100-base-pair Illumina
reads. We identiﬁed 123 unique, full-length toxin-coding sequences, which cluster into 78 groups with less than 1%
nucleotide divergence, and 2,879 unique, full-length nontoxin coding sequences. The toxin sequences accounted for
35.4% of the total reads, and the nontoxin sequences for an additional 27.5%. The most highly expressed toxin was a
small myotoxin related to crotamine, which accounted for 5.9% of the total reads. Snake-venommetalloproteinases
accounted for the highest percentage of reads mapping to a toxin class (24.4%), followed by C-type lectins (22.2%)
and serine proteinases (20.0%). The most diverse toxin classes were the C-type lectins (21 clusters), the snake-venom
metalloproteinases (16 clusters), and the serine proteinases (14 clusters). The high-abundance nontoxin transcripts
were predominantly those involved in protein folding and translation, consistent with the protein-secretory function
of the tissue.
Conclusions: We have provided the most complete characterization of the genes expressed in an active snake
venom gland to date, producing insights into snakebite pathology and guidance for snakebite treatment for the
largest rattlesnake species and arguably the most dangerous snake native to the United States of America, C.
adamanteus. We have more than doubled the number of sequenced toxins for this species and created extensive
genomic resources for snakes based entirely on de novo assembly of Illumina sequence data.
Background
Human envenomation by snakes is a worldwide issue
that claims more than 100,000 lives per year and exacts
untold costs in the form of pain, disﬁgurement, and loss
of limbs or limb function [1-3]. Despite the signiﬁcance
of snakebites, their treatments have remained largely
unchanged for decades. The only treatments currently
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available are traditional antivenoms derived from antisera
of animals, usually horses [4], innoculated with whole
venoms [5,6]; such an approach is the only readily avail-
able option for largely uncharacterized, complex mixtures
of proteins such as snake venoms. Although often lifesav-
ing and generally eﬀective against systemic eﬀects, these
antivenoms have little or no eﬀect on local hemorrhage
or necrosis [7-9], which are major aspects of the pathol-
ogy of viperid bites and can result in lifelong disability
[4,5]. These traditional treatments also sometimes lead to
adverse reactions in patients [6]. Advances in treatment
approaches will depend on a complete knowledge of the
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nature of the oﬀending toxins, but current estimates of
the numbers of unique toxins present in snake venoms
are in excess of 100 [10], a number not approached in
even the most extensive venom-characterization eﬀorts
to date [11].
The signiﬁcance of snake venoms extends well beyond
the selective pressures they may directly impose upon
human populations. Snake venoms have evolutionary
consequences for those species that snakes prey upon
[12,13], as well as species that prey upon the snakes
[14], and their study can therefore provide insights into
predator-prey coevolution. Snake venom components
have been leveraged as drugs and drug leads [15-17] and
have been used directly as tools for studying physiologi-
cal processes such as pain reception [18]. In addition to
the signiﬁcance of the toxins, the nature of the extreme
specialization of snake venom glands for the rapid but
temporary production and export of large quantities of
protein could provide insights into basic mechanisms of
proteostasis, the breakdown of which is thought to con-
tribute to neurodegenerative diseases such as Parkinson’s
and Alzheimer’s [19].
The eastern diamondback rattlesnake (Crotalus
adamanteus) is a pit viper native to the southeastern
United States and is the largest member of the genus
Crotalus, reaching lengths of up to 2.44 m [20]. The diet
of C. adamanteus consists primarily of small mammals
(e.g., squirrels, rabbits, and mouse and rat species) and
birds, particularly ground-nesting species such as quail
[20]. Because of its extreme size and consequent large
venom yield, C. adamanteus is arguably the most dan-
gerous snake species in the United States and is one of
the major sources of snakebite mortality throughout its
range [21]. Crotalus adamanteus has recently become of
interest from a conservation standpoint because of its
declining range, which at one time included seven states
along the southeastern Coastal Plain [22]. This species
has now apparently been extirpated from Louisiana and
is listed as endangered in North Carolina [23,24]. As a
consequence of recent work by Rokyta et al. [11] based
on 454 pyrosequencing, the venom of C. adamanteus is
among the best-characterized snake venoms; 40 toxins
have been identiﬁed.
Transcriptomic characterizations of venom glands
of snakes [25-28] and other animals [29-32] have
relied almost exclusively on low-throughput sequencing
approaches. Sanger sequencing, with its relatively long,
high-quality reads, has been the only method available
until recently and has provided invaluable data on the
identities of venom genes. Because venomous species
are primarily nonmodel organisms, high-throughput
sequencing approaches have been slow to pervade
the ﬁeld of venomics (but see Hu et al. [33]), despite
becoming commonplace in other transcriptomic-based
ﬁelds. Rokyta et al. [11] recently used 454 pyrosequenc-
ing to characterize venom genes for C. adamanteus. More
recently, Durban et al. [34] used 454 sequencing to study
the venom-gland transcriptomes of a mix of RNA from
eight species of Costa Rican snakes. Whittington et al.
[30] used a hybrid approach with both 454 and Illumina
sequencing to characterize the platypus venom-gland
transcriptome, although they had a reference genome
sequence, making de novo assembly unnecessary. Pyrose-
quencing is expensive and low-throughput relative to
Illumina sequencing, and the high error rate, particu-
larly for homopolymer errors [35], signiﬁcantly increases
the diﬃculty of identifying coding sequences without
reference sequences.
We sequenced the venom-gland transcriptome of the
eastern diamondback rattlesnake with Illumina technol-
ogy using a paired-end approach coupled with short
insert sizes eﬀectively to produce longer, high-quality
reads on the order of approximately 150 nt to facili-
tate de novo assembly (an approach similar to that of
Rodrigue et al. [36] for metagenomics). The diﬀerence in
read length from that of 454 sequencing was compensated
for by the increase of more than two orders of magni-
tude in the number of reads. We demonstrated de novo
assembly and analysis of a venom-gland transcriptome
using only Illumina sequences and provided a compre-
hensive characterization of both the toxin and nontoxin
genes expressed in an actively producing snake venom
gland.
Results and discussion
Venom-gland transcriptome sequencing and assembly
We generated a total of 95,643,958 pairs of reads that
passed the Illumina quality ﬁlter for>19 gigabases (Gb) of
sequence from a cDNA library with an average insert size
of ∼170 nt. Of these reads, 72,114,709 (75%) were merged
(see Methods) on the basis of their 3’ overlap (Figure 1),
yielding composite reads of average length 142 nt with
average phred qualities >40 and a total length >10 Gb.
This merging of reads reduced the eﬀective size of the data
set without loss of information and provided long reads to
facilitate accurate assembly.
Our ﬁrst approach to transcriptome assembly was
aimed at identifying toxin genes. We attempted to use as
many of the data as possible to ensure the identiﬁcation
of even the lowest-abundance toxins. To this end, we con-
ducted extensive searches of assembly parameter space for
both ABySS [37,38] (Table 1) and Velvet [39] on the basis
of the full set of both merged and unmerged reads. We
used the assemblies with the best N50 values for further
analysis. For Velvet, the assembly using a k-mer size of 91
was best (N50 = 408); this assembly was subsequently
analyzed with Oases [40]. For ABySS, the best k-mer value
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Figure 1Merging overlapping reads. (A) Reads are slid along each other until the number of matches exceeds the signiﬁcance threshold. In the
example shown, the optimal overlap is 74 nucleotides (nt). (B) The quality of reads declines dramatically toward their 3’ ends, where overlap occurs
if the fragment length is less than twice the read length, allowing the actual quality to be much higher than the nominal values. The example
shown is the average of pairs that overlap by exactly 50 nt.
Table 1 ABySS assembly summaries
Total Longest Contigs Contigs Total
k c e contigs contig >200 nt > N50 Median Mean N50 length
51 2 2 2,168,050 15,079 147,942 27,410 364 592 790 8.77 × 107
51 10 2 329,609 17,493 37,575 6,399 571 985 1,635 3.70 × 107
51 10 10 337,039 17,459 37,944 6,390 554 967 1,621 3.67 × 107
51 20 20 191,367 15,906 27,546 4,931 529 878 1,401 2.42 × 107
51 30 30 135,961 13,472 21,986 4,034 494 812 1,256 1.79 × 107
51 50 50 87,092 10,380 15,461 2,955 463 737 1,088 1.14 × 107
51 100 10 42,366 8,553 8,510 1,725 432 658 906 5.60 × 106
51 100 100 42,251 8,552 8,401 1,707 431 656 899 5.52 × 106
51 1000 1000 2,319 5,232 571 123 428 631 797 3.61 × 105
61 2 2 1,769,274 17,166 141,471 25,105 361 604 827 8.55 × 107
61 10 2 263,688 17,493 34,076 5,959 618 1,032 1,691 3.52 × 107
61 10 10 272,814 17,459 35,002 6,036 586 998 1,651 3.50 × 107
61 20 20 154,459 15,906 25,114 4,575 545 891 1,408 2.24 × 107
61 30 30 109,994 10,070 19,994 3,721 496 808 1,232 1.62 × 107
61 50 50 70,029 10,349 13,916 2,675 455 725 1,073 1.01 × 107
61 100 10 32,476 8,300 7,318 1,479 426 655 894 4.79 × 106
61 100 100 32,392 7,822 7,231 1,463 423 652 893 4.72 × 106
61 1000 1000 1,709 5,209 531 114 424 614 798 3.27 × 105
71 2 2 1,431,412 15,641 131,742 22,422 360 617 870 8.13 × 107
71 10 2 208,036 17,484 29,793 5,393 683 1,101 1,785 3.28 × 107
71 10 10 219,099 17,432 31,400 5,567 629 1,041 1,705 3.27 × 107
71 20 20 122,216 14,372 21,816 4,052 581 928 1,460 2.03 × 107
71 30 30 86,599 10,416 17,138 3,249 524 835 1,272 1.43 × 107
71 50 50 54,694 10,341 11,925 2,313 464 729 1,075 8.70 × 106
71 100 10 23,980 7,817 6,183 1,253 424 650 892 4.02 × 106
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Table 1 ABySS assembly summaries (Continued)
71 100 100 23,997 7,810 6,119 1,239 419 644 889 3.95 × 106
71 1000 1000 1,199 5,202 443 87 444 660 885 2.93 × 105
81 2 2 1,142,924 15,303 120,593 19,697 354 625 911 7.54 × 107
81 10 2 158,781 17,713 24,939 4,721 788 1,202 1,898 3.00 × 107
81 10 10 174,032 17,688 27,366 5,005 691 1,096 1,774 3.00 × 107
81 20 20 92,627 15,784 17,715 3,396 654 1,011 1,573 1.79 × 107
81 30 30 64,866 9,868 13,697 2,666 592 904 1,366 1.24 × 107
81 50 50 39,613 10,328 9,358 1,874 513 778 1,130 7.28 × 106
81 100 10 16,303 10,149 4,777 970 454 687 963 3.28 × 106
81 100 100 16,493 10,155 4,817 981 438 671 943 3.23 × 106
81 1000 1000 889 5,198 381 82 454 649 790 2.47 × 105
91 2 2 932,237 15,694 108,954 17,394 344 622 936 6.79 × 107
91 10 2 124,647 17,713 20,420 4,025 880 1,293 2,007 2.64 × 107
91 10 10 142,306 17,687 23,525 4,428 727 1,126 1,804 2.65 × 107
91 20 20 72,117 15,792 13,614 2,702 752 1,108 1,712 1.51 × 107
91 30 30 48,540 15,792 9,949 2,009 700 1,023 1,529 1.02 × 107
91 50 50 27,581 10,199 6,477 1,336 624 901 1,309 5.84 × 106
91 100 10 10,503 10,105 3,081 658 564 816 1,155 2.52 × 106
91 100 100 10,770 10,149 3,308 705 528 769 1,078 2.54 × 106
91 1000 1000 598 3,008 342 76 438 621 754 2.12 × 105
was also 91 (N50 = 2,007), but because the performance
in terms of full-length transcripts appeared to depend
strongly on the coverage (c) and erode (e) parameters, we
further analyzed the k = 91 assemblies with c = 10
and e = 2, c = 100 and e = 100, and c = 1000 and
e = 1000. We identiﬁed all full-length toxins by means of
blastx searches on the results of all four assemblies.
As part of our ﬁrst approach, we also performed
four independent de novo transcriptome assemblies with
NGen: three with 20 million merged reads each and one
with the remaining 12,114,709merged reads (Table 2).We
identiﬁed all full-length toxins from all four assemblies.
Given that all three assembly methods tended to generate
a large number of fragmented toxin sequences, apparently
because of retained introns and possibly alternative splic-
ing, we developed and implemented a simple hash-table
approach to completing partial transcripts, which we will
refer to as Extender (see Methods). We used Extender on
partial toxin sequences identiﬁed for two of the four NGen
assemblies. We also annotated the most abundant full-
length nontoxin transcripts for the three assemblies based
on 20 million reads. After combining all of the anno-
tated toxin and nontoxin sequences from the ABySS, Vel-
vet, and NGen assemblies and eliminating duplicates, we
had 72 unique toxin sequences and 234 unique nontoxin
sequences. The paucity of full-length annotated nontox-
ins reﬂects our focus on toxin sequences rather than their
absence in the assemblies.
Our second approach to transcriptome assembly
was designed to annotate as many full-length coding
sequences (toxin and nontoxin) as possible and to build
a reference database of sequences to facilitate the future
Table 2 NGen assembly summaries
No. contigs Assembled Unique full- Unique Extender
Assembly No. reads No. contigs >2k sequences length toxins toxins
NGen 1 20,000,000 12,694 4,403 9,786,054 34 54
NGen 2 20,000,000 12,746 4,439 9,821,212 36 54
NGen 3 20,000,000 12,698 4,412 9,820,553 38 –
NGen 4 12,114,709 8,484 3,078 5,948,003 34 –
Total unique full-length toxins = 154
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analysis of other snake venom-gland transcriptomes. We
found that NGen was much more successful at producing
transcripts with full-length coding sequences but also
that it was quite ineﬃcient when the coverage distribu-
tion was extremely uneven (see Figure 2). Feldmeyer et
al. [41] also found NGen to have the best assembly per-
formance with Illumina data. We sought therefore ﬁrst
to eliminate the transcripts and corresponding reads for
the extremely high-abundance sequences. To do so, we
employed Extender as a de novo assembler by starting
from 1,000 individual high-quality reads and attempting
to complete their transcripts (see Methods). From 1,000
seeds, we identiﬁed 318 full-length coding sequences with
213 toxins and 105 nontoxins. After duplicates were elim-
inated, this procedure resulted in 58 unique toxin and 44
unique nontoxin full-length transcripts. These sequences
were used to ﬁlter the corresponding reads from the full
set of merged reads with NGen. We then performed a de



























































































Figure 2 Domination of the C. adamanteus venom-gland transcriptome by toxin transcripts. The 123 unique toxin sequences were clustered
into 78 groups with less than 1% nucleotide divergence for estimation of abundances. (A) The vast majority of the extremely highly expressed
genes were toxins. The inset shows a magniﬁcation of the top 200 transcripts. (B) Expression levels of individual toxin clusters are shown with toxin
classes coded by color. The toxin clusters are in the same order as in Table 3.
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novo transcriptome assembly on 10 million of the ﬁltered
reads with NGen, annotated full-length transcripts from
contigs comprising ≥ 200 reads with signiﬁcant blastx
hits, and used the resulting unique sequences as a new ﬁl-
ter. This process of assembly, annotation, and ﬁltering was
iterated two more times. The end result was 91 unique
toxin and 2,851 unique nontoxin sequences.
The results from both assembly approaches were
merged to yield the ﬁnal data set. The ﬁrst approach
produced 72 unique toxin and 234 unique nontoxin
sequences, and the second 91 toxin and 2,851 non-
toxin sequences. The merged data set consisted of
123 unique toxin sequences and 2,879 nontoxins that
together accounted for 62.9% of the sequencing reads
(Figure 3).
Toxin transcripts
We identiﬁed 123 individual, unique toxin transcripts with
full-length coding sequences. To estimate the abundances
of these transcripts in the C. adamanteus venom-gland
transcriptome, we clustered them into 78 groups with less
than 1% nt divergence (Table 3). Clusters could include
alleles, recent duplicates, or even sequencing errors,
which are characteristic of high-throughput sequencing
[42]. For longer genes, clusters might also include diﬀerent
combinations of variable sites that are widely separated in
the sequence. We chose 1% as a practical, but arbitrary,
cut-oﬀ for deﬁning clusters. Mapping reads back to more
similar sequences to estimate abundances would be prob-
lematic because reads could not be uniquely assigned to
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Figure 3 Expression levels of major classes of toxins and nontoxins.More than 60% of the total reads have been accounted for with full-length
annotated transcripts. (A) The major toxin classes were the CTLs, SVSPs, MYO, and SVMPs (types II and III). (B) As expected for a protein-secreting
tissue, the venom gland expresses an abundance of proteins involved in proteostasis.
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Table 3 Expression levels of full-length toxin clusters
Rank Cluster name Cluster size Length % total reads % toxin reads GenBank TSA accessions
1 MYO 1 994 5.93 16.780 JU173668
2 LAAO 1 3089 1.88 5.309 JU173667
3 SVSP-6 1 1720 1.71 4.849 JU173733
4 CTL-8 3 721 1.02 2.896 a:JU173656,
b:JU173657,
c:JU173658
5 SVSP-13 1 1661 1.01 2.864 JU173724
6 PLA2-1 2 904 9.68 × 10−1 2.739 a:JU173675,
b:JU173676
7 SVSP-3 2 1830 9.38 × 10−1 2.653 a:JU173728,
b:JU173729























12 SVMPII-2 2 2138 8.38 × 10−1 2.369 a:JU173687,
b:JU173688
13 SVSP-1 1 3120 8.30 × 10−1 2.348 JU173726
14 CTL-16 1 711 7.82 × 10−1 2.211 JU173631
15 SVMPII-7 1 2082 7.74 × 10−1 2.191 JU173703




17 PLA2-4 1 890 6.98 × 10−1 1.974 JU173679
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Table 3 Expression levels of full-length toxin clusters (Continued)






19 SVMPII-6 1 2183 6.31 × 10−1 1.784 JU173702
20 SVMPIII-3 3 2401 6.00 × 10−1 1.698 a:JU173712,
b:JU173713,
c:JU173714
21 SVSP-9 1 10270 5.96 × 10−1 1.685 JU173738
22 SVMPII-4 1 2016 5.41 × 10−1 1.530 JU173693
23 SVSP-8 1 3524 5.41 × 10−1 1.529 JU173737
24 CTL-7 1 763 5.40 × 10−1 1.528 JU173655
25 CTL-18 1 775 5.33 × 10−1 1.509 JU173633
26 CTL-1 1 763 5.15 × 10−1 1.458 JU173635
27 SVSP-12 1 957 5.04 × 10−1 1.424 JU173723
28 CTL-6 1 607 4.80 × 10−1 1.358 JU173654
29 CRISP 1 1579 4.66 × 10−1 1.317 JU173623
30 SVMPIII-7 1 2343 4.31 × 10−1 1.218 JU173719
31 SVMPII-8 1 1863 4.24 × 10−1 1.198 JU173704
32 PLA2-6 1 834 4.15 × 10−1 1.174 JU173681
33 SVSP-7 3 2108 3.59 × 10−1 1.016 a:JU173734,
b:JU173735,
c:JU173736
34 CTL-15 1 947 3.59 × 10−1 1.016 JU173630
35 PLA2-2 1 872 3.58 × 10−1 1.013 JU173677
36 CTL-10 1 587 3.49 × 10−1 0.987 JU173624
37 CTL-14 1 1246 3.36 × 10−1 0.951 JU173629
38 CTL-13 1 680 3.15 × 10−1 0.891 JU173628
39 PLA2-5 1 651 2.90 × 10−1 0.819 JU173680
40 CTL-9 2 755 2.88 × 10−1 0.814 a:JU173659,
b:JU173660
41 BPP 1 1300 2.57 × 10−1 0.726 JU173621
42 SVMPIII-1 2 2665 2.41 × 10−1 0.683 a:JU173705,
b:JU173706
43 SVSP-14 1 1732 2.23 × 10−1 0.631 JU173725
44 SVMPIII-4 2 2433 2.16 × 10−1 0.611 a:JU173715,
b:JU173716
45 CTL-2 2 749 1.90 × 10−1 0.538 a:JU173638,
b:JU173639
46 SVMPIII-8 1 2150 1.71 × 10−1 0.484 JU173720
47 VESP 1 1603 1.71 × 10−1 0.483 JU173741
48 SVMPIII-5 1 2339 1.59 × 10−1 0.449 JU173717
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Table 3 Expression levels of full-length toxin clusters (Continued)
49 SVSP-4 2 2152 1.34 × 10−1 0.379 a:JU173730,
b:JU173731
50 CTL-20 1 785 1.19 × 10−1 0.336 JU173636
51 NUC 1 2706 1.16 × 10−1 0.327 JU173671
52 SVSP-5 1 1890 1.12 × 10−1 0.317 JU173732
53 SVMPIII-6 1 2367 1.10 × 10−1 0.311 JU173718
54 CTL-21 1 824 1.09 × 10−1 0.307 JU173637
55 CTL-19 1 618 1.05 × 10−1 0.296 JU173634
56 NF 1 1395 9.53 × 10−2 0.269 JU173669
57 CTL-12 2 825 9.40 × 10−2 0.266 a:JU173626,
b:JU173627
58 SVSP-2 1 1675 7.35 × 10−2 0.208 JU173727
59 CTL-5 3 637 5.83 × 10−2 0.165 a:JU173651,
b:JU173652,
c:JU173653
60 PDE 1 2743 5.62 × 10−2 0.159 JU173674
61 CTL-11 1 625 4.86 × 10−2 0.137 JU173625
62 PLA2-3 1 957 3.22 × 10−2 0.091 JU173678
63 CREGF 1 1945 3.09 × 10−2 0.087 JU173622
64 SVSP-10 1 1815 2.22 × 10−2 0.063 JU173721
65 HYAL-1 1 2545 2.10 × 10−2 0.059 JU173662
66 KUN 1 1698 1.14 × 10−2 0.032 JU173666
67 HYAL-2 1 1302 7.83 × 10−3 0.022 JU173663
68 KUN-1 1 2575 5.11 × 10−3 0.014 JU173664
69 VEGF-1 2 906 4.99 × 10−3 0.014 a:JU173739,
b:JU173740
70 SVSP-11 1 1207 4.46 × 10−3 0.013 JU173722
71 GC 1 1730 3.65 × 10−3 0.010 JU173661
72 PDE-6 1 3691 3.36 × 10−3 0.010 JU173673
73 NGF 1 951 3.14 × 10−3 0.009 JU173670
74 KUN-2 1 1438 2.68 × 10−3 0.008 JU173665
75 PDE-4 1 2633 2.24 × 10−3 0.006 JU173672
76 VF 1 5087 1.70 × 10−3 0.005 JU173742
77 WAP 1 627 5.60 × 10−4 0.002 JU173743
78 CTL-17 1 774 3.80 × 10−4 0.001 JU173632
for C. adamanteus probably lies somewhere between 78
and 123. This range is at the lower end of the number
of unique toxins typically identiﬁed for viperids by means
of proteomic techniques [10], which may indicate that
the venom of C. adamanteus is less complex than that of
other species. Alternatively, posttranscriptional processes
such as alternative splicing or posttranslational modiﬁca-
tions could signiﬁcantly increase the diversity of toxins
present in the venom. Our identiﬁed toxins accounted for
35.4% of the total reads (Figure 3), and the vast majority
of the extremely high-abundance transcripts were those
encoding toxin proteins (Figure 2A). We named toxins
with a combination of a toxin-class abbreviation, a cluster
number, and, if the cluster hadmore than a singlemember,
a lower-case letter to indicate the member of the cluster
(e.g., CTL-3b).
We used the number or percentage of reads mapping
to a particular transcript as a measure of its abundance.
Although average coverage might be a more appropriate
proxy for the number of copies of a given transcript
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present, because it accounts for diﬀerences in transcript
lengths, we prefer read counts as a measure of the expres-
sion expenditure on a given transcript because they better
reﬂect the energetic cost associated with producing the
encoded protein and are consistent with previous work
using low-throughput sequencing (see, e.g., Pahari et al.
[25]). In addition, this measurement should more closely
match proteomic-based measurements of the contents of
venom components (see, e.g., Gibbs et al. [43]) which
come in the form of the percentages of total peptide bonds
in the sample.
Snake venommetalloproteinases
We identiﬁed 39 unique sequences and 16 clusters of
snake-venommetalloproteinases (SVMPs) that accounted
for 24.4% of the reads mapping to toxin sequences and
8.6% of the total reads (Figure 3A and Table 3). In terms
of total reads, the SVMPs were the most abundant class of
toxins in the C. adamanteus venom-gland transcriptome.
SVMPs are the primary sources of the local and systemic
hemorrhage associated with envenomation by viperids
and are divided into a number of subclasses based on
their domain structure [44,45]. All SVMPs have a metallo-
proteinase domain characterized by a zinc-binding motif.
All of the SVMPs identiﬁed for C. adamanteus belong to
either the type II or the type III subclass. Type II SVMPs
(SVMPIIs) have a disintegrin domain in addition to the
metalloproteinase domain, which may be proteolytically
cleaved posttranslationally to produce a free disintegrin.
Type III SVMPs (SVMPIIIs) have a disintegrin-like and a
cysteine-rich domain in addition to the metalloproteinase
domain. We found 8 clusters of each of these two sub-
classes with 23 unique SVMPII sequences and 16 unique
SVMPIII sequences. SVMPII and SVMPIII clusters com-
prise 16.4% and 8.0% of the reads mapping to toxins
respectively (Figure 3). The sequences in both subclasses
are diverse. The maximum pairwise nt divergence for the
SVMPIIs was 10.0%, corresponding to amaximum amino-
acid divergence of 18.1%. For the SVMPIIIs, the maxi-
mum pairwise nt divergence was 20.4% with a maximum
amino-acid divergence of 42.3%. Although SVMPs were
the dominant toxins as a class, the individual SVMP clus-
ter with the highest abundance was SVMPII-5, which was
only the eighth most abundant toxin cluster (Figure 2B
and Table 3).
Mackessy [46] categorized rattlesnake venoms as type
I or type II on the basis of their toxicities and metallo-
proteinase activities. These two measurements tend to be
inversely related in rattlesnakes: species (or populations)
with low LD50 values tend also to have low or undetectable
hemorrhagic activities. SVMPs are themajor hemorrhagic
components of snake venoms, and high toxicity appears
to be caused mostly by neurotoxic venom components.
Low-toxicity venoms with high metalloproteinase activity
are classiﬁed as type I, and high-toxicity venoms with low
metalloproteinase activity are classiﬁed as type II. On the
basis of the abundance of SVMPs in the venom-gland
transcriptome, C. adamanteus clearly has type I venom,
although the relatively low toxicity of its venom [46] is
at least partially compensated for by its large size and
venom yield.
C-type lectins
The most diverse and the second most abundant toxin
class in the C. adamanteus venom-gland transcriptome
was the C-type lectin (CTL) class.We identiﬁed 37 unique
sequences and 21 clusters of CTLs that accounted for
22.2% of the reads mapping to toxins and 7.8% of the
total reads (Figure 3A and Table 3). CTLs generally either
inhibit or activate components of plasma or blood-cell
types, thereby interfering with hemostasis [47]. Most
known snake-venom CTLs function as heterodimers or
even more complex arrangements [48], probably account-
ing in part for their diversity. The divergence among
members of this class within the C. adamanteus genome
was extreme, although all members preserved a CTL-like
domain. Some pairs shared virtually no conserved amino-
acid positions. Three of the CTL clusters provide evidence
for the relevance of alternative splicing in the generation
of toxin proteins. CTL-3f, CTL-4e, and CTL9b all have 48-
nt insertions in the same region but are otherwise similar
or identical to other members of their clusters.
Snake venom serine proteinases
The third most abundant toxin class for C. adaman-
teus was the snake-venom serine proteinases (SVSPs). We
identiﬁed 18 unique sequences and 14 clusters in this
toxin class, accounting for 20.0% of the toxin reads and
7.1% of the total reads (Figure 3A and Table 3). Three of
the 10most highly expressed individual toxins were SVSPs
(Figure 2). SVSPs interfere with a wide array of reactions
involving blood coagulation and hemostasis and belong to
the trypsin family of serine proteases [49,50]. Mackessy
[46] detected signiﬁcant thrombin-like and kallikrein-
like activity in the venom of C. adamanteus, which are
attributable to the action of SVSPs. The diversity of SVSPs
within theC. adamanteus genome is high; maximum pair-
wise nt divergence is 20.6% and amino-acid divergence
is 47.4%.
The members of two SVSP clusters diﬀer in a way
that should be noted. The lengths of SVSPs are gener-
ally well conserved throughout the class. SVSP-7a has a
27-nt insertion relative to the two other members of its
cluster but is otherwise identical to SVSP-7b. This diﬀer-
ence could reﬂect the presence of alternative splicing for
this gene. SVSP-3a is unique among the C. adamanteus
SVSPs or those known from other snake species in appar-
ently having a 65-amino-acid extension of its C-terminal
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region. The other member of its cluster, SVSP-3b, has a
single deletion of a C nt in a poly-C tract that terminates
its coding sequence consistently with other known SVSPs.
The reads generating the SVSP-3a form vastly outnum-
ber those for the SVSP-3b form; more than 95% of the
reads support the extended version of the protein. The
eﬀect, if any, of this C-terminal extension remains to be
determined.
Phospholipase A2’s
Previous work with C. adamanteus identiﬁed only a single
phospholipase A2 (PLA2) sequence [11], but we iden-
tifed seven unique sequences in six clusters (Figure 2
and Table 3), accounting for 7.8% of the toxin reads and
2.8% of the total reads (Figure 3). PLA2s are among the
most functionally diverse classes of snake-venom toxins
and have pharmocological eﬀects ranging from neuro-
toxicity (presynaptic or postsynaptic) to myotoxicity and
cardiotoxicity. Anticoagulant and hemolytic eﬀects due to
PLA2s are also known [51,52]. Compared to other toxin
classes of C. adamanteus, the diversity of PLA2s is low.
Five of the six clusters are all within 5% nt divergence of
one another. PLA2-3 is the lone, high-divergence outlier,
diﬀering by more than 31% at the nt level from the other
clusters. PLA2-3 is also expressed at the lowest level of any
of the PLA2s (Table 3).
Other high-abundance toxins
The SVMPs, CTLs, SVSPs, and PLA2s account for 74% of
the reads mapping to toxin sequences (Figure 3), 73% of
the toxin clusters, and 82% of the unique toxin sequences.
The remaining toxins belong to 16 diﬀerent classes. Many
of these are low-abundance transcripts (Figure 2 and
Table 3) and may not actually function as signiﬁcant
toxins, whereas several others have high to moderate
abundances and represent signiﬁcant components of the
venom.
The most abundant toxin transcript and the most
abundant transcript overall (Figure 2) was a small basic
myotoxin related to crotamine [53,54]. The precursor pro-
tein is just 70 amino acids in length with a predicted 22-
amino-acid signal peptide. This transcript was detected
by Rokyta et al. [11], but the coding sequence was prema-
turely truncated in their sequence because of a single nt
deletion. This toxin accounts for 16.8% of the toxin reads
(Figure 3A) and 5.9% of the total reads. Crotamine, origi-
nally isolated from the venom of C. durissus, causes spas-
tic paralysis in mice and is found in the venoms of many
species of Crotalus [54]. Muscle spasms, twitching, and
paralysis of the legs have been reported for human enven-
omations by C. adamanteus [20]. Interestingly, Straight
et al. [55] noted that individuals of C. adamanteus from
populations in southern and central Florida lack this toxin
in their venoms. Given that this myotoxin is the most
abundant transcript in the venom of our specimen, its
absence in southern populations points to a dramatic dif-
ference in venoms within this species and the potential for
signiﬁcantly diﬀerent pathological eﬀects associated with
bites from diﬀerent C. adamanteus populations.
A single L-amino-acid oxidase (LAAO) transcript was
the second most abundant toxin transcript (Figure 2B),
consistent with the previously detected LAAO activity
in the C. adamanteus venom [46]. This single tran-
script accounted for 5.3% of the reads mapping to toxins
and 1.9% of the total reads. LAAOs are ﬂavoproteins,
giving the venom its yellow color; can be edema- or
apoptosis-inducing; and can induce or inhibit platelet
aggregation [56]. These eﬀects are probably mediated by
H2O2 released during the oxidation reaction catalyzed
by the enzyme. The 29th most abundant toxin transcript
was a cysteine-rich secretory protein (CRISP) (Figure 2B
and Table 3), accounting for 1.3% of the toxin reads
(Figure 3A). Although CRISPs are widely found in snake
venoms, their precise eﬀects are not well established
[57], but they appear to interfere with smooth-muscle
contraction [58,59]. A single transcript for a bradykinin-
potentiating and C-type natriuretic peptide transcript
(BPP) was found to account for 0.7% of the toxin reads
(Figure 3A). The encoded protein is similar to a pro-
tein identiﬁed in Sistrurus catenatus (GenBank accession:
DQ464265) that was hypothesized to reduce blood pres-
sure in envenomated prey [25]. A loss of blood pres-
sure has been reported in human envenomations by
C. adamanteus [20].
Other low-abundance toxins
The remaining 17 clusters are classiﬁed as “others” in
Figure 3A. Because each has a relatively low expression
level (Table 3), many of these should be considered puta-
tive toxins until their presence in the C. adamanteus
venom is conﬁrmed proteomically and pharmacological
eﬀects are associated with them.
Rokyta et al. [11] detected the presence of a transcript
encoding a protein homologous to ohanin from Ophioph-
agus hannah [60,61] and to a homologous protein from
Lachesis muta [62]; we found a transcript identical to
that of Rokyta et al. [11]. Pung et al. [60,61] found the
O. hannah version of this protein to increase pain sensi-
tivity (hyperalgesia) and to induce temporary hypoloco-
motion in mice and proposed naming the class vespryns
(VESP). Exceptionally intense pain has been reported
after envenomation of humans by C. adamanteus [20],
although whether such pain is due to a speciﬁc toxin is
not clear.
We detected three diﬀerent nucleotidases (NUCs) and
ﬁve diﬀerent phosphodiesterases (PDEs) in the venom-
gland transcriptome of C. adamanteus. Only one of the
NUCs and three of the PDEs had signal peptides, and
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we therefore only considered these as potential toxins:
NUC, PDE, PDE-4, and PDE-6 (Table 3). The roles of
these enzymes in venoms are uncertain, but their primary
function may be to liberate toxic nucleosides [63-65].
Signiﬁcant PDE activity has been detected previously in
the venom of C. adamanteus [46].
The C. adamanteus venom-gland transcriptome con-
tained three Kunitz-type protease inhibitors (KUNs).
Two of these shared more than 75% animo-acid identity
with a KUN from Austrelaps labialis (GenBank acces-
sion: B2BS84), an Australian elapid. All three KUNs have
domains that place them in the superfamily of bovine pan-
creatic trypsin-like inhibitors, and snake toxins from this
family are known to inhibit plasma serine proteinases.
AlthoughKUNs are commonly observed in snake venoms,
their role in envenomation (if any) is not well deﬁned [66].
The three KUNs detected for C. adamanteus are all at rel-
atively low abundances, suggesting that they are not major
components of the venom.
We identiﬁed two transcripts, HYAL-1 and HYAL-2,
encoding hyaluronidase-like proteins. Hyaluronidases are
generally regarded as venom components that promote
the dissemination of other venom components by degrad-
ing the extracellular matrix at the site of injection [67],
although they may have more direct toxic eﬀects [68].
The coding sequences of our two transcripts diﬀer only
in the presence of a 765-nt deletion in HYAL-2 relative to
HYAL-1. Truncated hyaluronidases such as HYAL-2 have
been detected in the venoms of other viperid species [67]
and may represent an example of alternative splicing. We
also identiﬁed a transcript encoding a glutaminyl-peptide
cyclotransferase (glutaminyl cyclase; GC). Many snake
venom components have N termini blocked by pyrogluta-
mate, and GCs catalyze the formation of this block. This
component is related more to maturation and protection
of other toxins and probably contributes only indirectly to
toxicity [69].
We identiﬁed six growth-factor-related sequences in the
venom-gland transcriptome of C. adamanteus: a nerve
growth factor (NGF), a neurotrophic factor (NF), two
vascular endothelial growth factors (VEGF) in a sin-
gle cluster, and a cysteine-rich with EGF-like domain
protein (CREGF). The NGF transcript encodes a 241
amino-acid precursor protein and shares 99% amino-
acid identity with a NGF from C. durissus (GenBank
accession: AAG30924). The NF transcript encodes a 180-
amino-acid precursor that shares homology with mes-
encephalic astrocyte-derived neurotrophic factors. We
found no close venom-related sequences for this NF in
the available databases. The VEGF sequences appear to
be alternatively spliced versions of one another. VEGF-
1a encodes a 192-amino-acid precursor, and VEGF-1b
encodes a 148-amino-acid precursor. Aside from the
132-nt deletion in VEGF-1b relative to VEGF-1a, their
coding sequences are identical. Both forms have database
matches of the same length with 99% amino-acid iden-
tity from Trimeresurus ﬂavoviridis (GenBank accessions:
AB154418 and AB154419). Finally, we detected the same
cysteine-rich with EGF-like domain protein as described
by Rokyta et al. [11].
The ﬁnal two putative toxin transcripts are of question-
able signiﬁcance because of their low expression levels.
A single sequence with 77% amino-acid identity to a
waprin (WAP) sequence from Philodryas olfersii (Gen-
Bank accession: EU029742), a rear-fanged colubrid, was
detected. Related sequences have been detected in a vari-
ety of other rear-fanged snake species, but such proteins
are only known to exhibit antimicrobial activity [70]. We
detected a venom factor (VF) transcript that shares 87%
animo-acid identity with a VF from Austrelaps superbus
(GenBank accession: AY903291) [71]. The C. adamanteus
VF transcript encodes a 1,652-amino-acid precursor with
a 22-amino-acid signal peptide. The best-studied member
of this toxin family is cobra venom factor, which is known
to activate the complement system [72]. The extremely
low expression levels of these transcripts may indicate that
they represent the orthologous genes to the ancestors of
the known toxic forms and may therefore have no toxic
functions.
Comparison to previous work
Rokyta et al. [11] previously described toxin transcripts in
the venom-gland transcriptome of C. adamanteus on the
basis of 454 pyrosequencing. Their work used RNA from
the venom gland of the same individual used in the present
work. They found 40 unique toxin transcripts, 10 of which
contained only partial coding sequences. Table 4 lists the
closest matches from our current sequences to those of
Rokyta et al. [11]. The vast majority of the 454-based
sequences had either identical matches in our current
set of toxins or matches with less than 1% nt divergence
(Table 4). Only a single 454 toxin, SVSP-9, did not have
a close match. This sequence contains only a partial cod-
ing sequence and therefore may not represent a true,
functional toxin.
Nontoxin transcripts
We characterized the nontoxin genes expressed in the
C. adamanteus venom gland by two means. First, we
took all of the contigs from one of our four de novo
NGen assemblies based on 20 million merged reads and
conducted a full Blast2Go [73] analysis on the contigs
comprising ≥100 reads. Of the 12,746 contigs (assem-
bly 2 in Table 2), we were able to provide gene ontology
(GO) annotations for 9,040 of them (Figure 4A). The
major functional classes (level 2) represented in these
results were binding and catalysis, followed by transcrip-
tion regulation (Figure 4B). The major biological process
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Table 4 Correspondence with the results of Rokyta et al. [11]
454 name Accession Closest match % nt divergence Notes
CREGF HQ414087 CREGF 0.1
CRISP HQ414088 CRISP 0.0 Identical
CTL-1 HQ414089 CTL-4a 0.0 Identical
CTL-2 HQ414090 CTL-8a 0.0 Identical
CTL-3 HQ414091 CTL-1 0.0 Identical
CTL-4 HQ414092 CTL-9a 0.8
CTL-5 HQ414093 CTL-3e 0.9
CTL-6 HQ414094 CTL-12b 0.0 Identical
CTL-7 HQ414095 CTL-10 0.0 Identical
CTL-8 HQ414096 CTL-2a 0.0 Identical
CTL-9 HQ414097 CTL-5a 0.0 Identical
HYAL HQ414098 HYAL-1 0.0 454 version incomplete
LAAO HQ414099 LAAO 0.0 Identical
MYO HQ414100 MYO 0.0 454 version has 1-nt deletion that truncates the coding sequence prematurely
NUC HQ414101 NUC 0.0 454 version incomplete
PDE-1 HQ414102 PDE 0.0 454 version has 123-nt insertion
PDE-2 HQ414103 PDE-2 (nontoxin) 0.0 454 version incomplete; no signal peptide; no longer considered toxin
PLA2 HQ414104 PLA2-1b 0.0 Identical
PLB HQ414105 PLB (nontoxin) 0.2 No longer considered toxin
SVMP-1 HQ414106 SVMPII-3b 0.0 Identical
SVMP-2 HQ414107 SVMPII-3b/c 0.5
SVMP-3 HQ414108 SVMPII-5a 0.3
SVMP-4 HQ414109 SVMPIII-2d 1.2
SVMP-5 HQ414110 SVMPIII-4b 1.0
SVMP-6 HQ414111 SVMPIII-2d 0.2
SVMP-7 HQ414112 SVMPIII-4a 0.0 Identical
SVMP-8 HQ414113 SVMPIII-5 0.5 454 version incomplete
SVMP-9 HQ414114 SVMPIII-1a/b 0.0 454 version incomplete
SVMP-10 HQ414115 SVMPIII-6 0.0 454 version incomplete
SVMP-11 HQ414116 SVMPIII-3a 0.0 454 version incomplete
SVSP-1 HQ414117 SVSP-3a 0.0 454 version has 1-nt deletion that truncates the coding sequence prematurely
SVSP-2 HQ414118 SVSP-1 0.0 Identical
SVSP-3 HQ414119 SVSP-7a 0.0 Identical
SVSP-4 HQ414120 SVSP-5 0.1
SVSP-5 HQ414121 SVSP-9 0.5
SVSP-6 HQ414122 SVSP-6 0.0 Identical
SVSP-7 HQ414123 SVSP-4b 0.0 454 version incomplete
SVSP-8 HQ414124 SVSP-2 0.0 454 version incomplete
SVSP-9 HQ414125 None > 10 454 version incomplete
VESP HQ414126 VESP 0.0 Identical
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Figure 4 Comparison of gene ontology (GO) results for our annotated full-length nontoxin sequences with those of the contigs from a de
novo assembly with NGen. Only level 2 GO terms are shown. The distributions of GO terms are similar across data sets, suggesting that the
annotated transcripts provided a comprehensive characterization of the genes expressed in the venom gland. (A) The distributions of sequences
reaching various stages of identiﬁcation and annotation are shown. The level 2 GO terms are shown for molecular function (B), biological process
(C), and cellular component (D).
GO terms (level 2) were cellular processes and metabolic
processes (Figure 4C). Interestingly, viral reproductive
function was detected and probably represents the activ-
ity of transposable elements or retroviruses like those
previously noted in snake venom-gland transcriptomes
[34]. The major cellular component GO terms (level 2)
were cell and organelle (Figure 4D). For these results, we
made no attempt to exclude toxin sequences, because they
are necessarily a small minority of the total sequences,
and did not require that contigs contain full-length
coding sequences.
For our second approach, we used only the 2,879 tran-
scripts with full-length coding sequences for nontoxin
proteins. We analyzed these sequences with Blast2GO.
The distributions of level 2 GO terms for these data
were almost identical to those of the full NGen assem-
bly described above (Figure 4), suggesting that our 2,879
annotated nontoxin sequences provide a representative
sample of the full venom-gland transcriptome. The full
distributions of GO terms for these sequences across all
levels are shown in Figures 5, 6, and 7. As expected for
a secretory tissue, processes related to protein produc-
tion and secretion were well represented (e.g., protein
transport and protein modiﬁcation; Figure 5), as were
protein-binding functions (Figure 6) and proteins local-
ized to the endoplasmic reticulum (ER) and the Golgi
apparatus (Figure 7).
Four of the top 20 most highly expressed nontoxin
genes (Table 5), including the most highly expressed,
were protein disulﬁde isomerases (PDIs). In particular,
they were members of the PDI family that is retained
in the ER and are characterized by having two or more
PDI domains, which are similar to thioredoxin. PDIs cat-
alyze the formation or breaking of disulﬁde bonds and are
therefore involved in protein folding. Molecular chaper-
ones were well represented in the top 20 nontoxins by
four genes: endoplasmin (a member of the HSP90 family),
calreticulin, 78-kDA glucose-regulated protein (GRP78),



































































































































































































Figure 5 The biological-process GO terms identiﬁed for the 2,879 annotated full-length nontoxin sequences. Terms speciﬁc for the
production, processing, and export of proteins are highlighted in black. The inset shows the low-abundance portion of the full distribution.
and heat shock protein 5. The latter gene appears to be
a splice variant of GRP78, diﬀering within the coding
region by two point mutations and two short deletions.
All of these chaperones are ER speciﬁc. Six of the top 20
nontoxins were mitochondrial genes involved in oxida-
tive cellular respiration, consistent with the high ener-
getic demands of venom production [74]: cytochrome C
oxidase subunits I and III, cytochrome B, and NADH
dehydrogenase subunits 1, 4, and 5. The cells of venom
glands are particularly rich in mitochondria [75]. Four
genes were involved in various aspects of translation:
two translation elongation factors, 18S rRNA, and vig-
ilin. Vigilins are hypothesized to be involved in reg-
ulating mRNA stability and translation and might be
involved in RNA-mediated gene silencing [76,77]. The
ﬁnal top 20 nontoxin gene was actin, a component of the
cytoskeleton.
The abundances of several major classes of nontoxins
are provided in Figure 3B.We identiﬁed 57 sequences with
functions related to protein folding [19,78-80], including
various classes of heat-shock proteins, protein-disulﬁde
isomerases, peptidyl-prolyl cis-trans isomerases, dnaJ-
complex components, and T-complex components. These
sequences together accounted for 28.4% of the total
reads mapping to nontoxins. Ribosomal-protein tran-
scripts (cytoplasmic and mitochondrial) accounted for
9.5% of the nontoxin reads, and mitochondrial genes
accounted for another 9.0%. Finally, we identiﬁed 110
sequences transcripts encoding proteins involved in pro-
tein degradation [81,82], including proteins involved in
the ubiquitin-proteasome system and the ER-associated
protein-degradation system [83], which accounted for
2.6% of the nontoxin reads. Protein-quality control should
be essential in a high-throughput protein-producing tis-
sue such as a snake venom gland.
Our collection of nontoxins included several notable
potential inhibitors of the toxins or other proteases
(Table 6). Such inhibitors may play a role in preventing
autolysis [84] or may serve to protect venom components
once inside a victim [85]. We detected three cystatin-like
transcripts in the venom gland. Cystatins are cysteine-
protease inhibitors and have been detected in numerous
elapid venom glands and venoms [85]. We detected three
unique metalloproteinase inhibitors and two serine pro-
teinase inhibitors (serpins). Finally, we found four unique
PLA2 inhibitors.
Sequence accession numbers
The original, unmerged sequencing reads were submit-
ted to the National Center for Biotechnology Information
(NCBI) Sequence Read Archive under accession number
SRA050594. The annotated toxin and nontoxin sequences












































































































Figure 6 The molecular-function GO terms identiﬁed for the 2,879 annotated full-length nontoxin sequences. Terms speciﬁc for the
production, processing, and export of proteins are highlighted in black. The inset shows the low-abundance portion of the full distribution.
were submitted to the GenBank Transcriptome Shot-
gun Assembly (TSA) database under accession numbers
JU173621–JU173743 (toxins) and JU173744–JU176622
(nontoxins).
Conclusions
We have described the most comprehensive venom-gland
transcriptomic characterization of a snake species to
date and provided full-length coding sequences for 123
unique toxin proteins and 2,879 unique nontoxin proteins.
We have demonstrated the use of Illumina sequencing
technology for the sequencing and de novo assembly of
a tissue-speciﬁc transcriptome for a nonmodel species,
C. adamanteus, for which genome-scale resources were
previously unavailable. Because the nontoxin sequences in
particular should be conserved across snake species, our
results should greatly facilitate similar work with other
venomous species, serving as an assembly template and
reducing the number of reads for which de novo assembly
will be necessary.
The expressed toxin genes in the venom gland of
C. adamanteus provide a detailed portrait of a type I
rattlesnake venom [46]. The most abundant transcript
expressed in the C. adamanteus venom gland encoded
a myotoxin homologous to crotamine. Crotamine is
known to induce spastic paralysis [54], a symptom
that has been observed in human envenomations by
C. adamanteus [20]. Like those of most viperids, the
bites of C. adamanteus result in signiﬁcant tissue dam-
age and necrosis, and we found that SVMPs, the major
class of hemorrhagic toxins, dominated venom-gland
gene expression. The second most abundant toxin tran-
script overall was an LAAO, which are also noted for
causing local tissue damage [46]. Coagulopathy is a
common occurrence with pit-viper bites [5]. The CTLs
and SVSPs were also both diverse and abundant in the
venom-gland transcriptome of C. adamanteus, and both
classes primarily attack the hemostatic system. In terms
of gene sequences of venom components, the venom of
C. adamanteus is now the best-characterized snake
venom, although a thorough proteomic analysis of the
venom is still needed. The sequences we have generated
will greatly facilitate such a proteomic characteriza-
tion by serving as a database against which to query
mass-spectrum results.
The expression patterns of the nontoxin genes in the
venom gland of C. adamanteus reﬂect the protein-
secretory function of the tissue and the high energetic


















































































































































Figure 7 The cellular-components GO terms identiﬁed for the 2,879 annotated full-length nontoxin sequences. Terms speciﬁc for the
production, processing, and export of proteins are highlighted in black. The inset shows the low-abundance portion of the full distribution.
demands of rapid venomproduction [75]. Themost highly
expressed nontoxin genes were those involved in the
production and processing of proteins and energy pro-
duction to support these activities. Molecular chaperones
and PDIs were particularly abundant. Though the expres-
sion patterns for nontoxins were not surprising, future
comparisons with other snake species, especially those
from other snake families, may be able to elucidate the ori-
gin and early stages of the evolution of the venom gland.
Methods
Venom-gland transcriptome sequencing
We sequenced the venom-gland transcriptome of a sin-
gle animal from Florida (Wakulla County): an adult female
weighing 393 g with a snout-to-vent length of 792mm and
a total length of 844 mm. To stimulate transcription in
the venom glands, we anesthetized the snake by propofol
injection (10 mg/kg) and extracted venom by electros-
timulation under anesthesia [86]. After venom extraction,
the animal was allowed to recover for four days while
transcription levels reached their maxima [87]. The snake
was euthanized by injection of sodium pentobarbitol (100
mg/kg), and its venom glands were subsequently removed.
The above techniques were approved by the Florida State
University Institutional Animal Care and Use Committee
(IACUC) under protocol #0924.
Sequencing and nonnormalized cDNA library prepa-
ration were performed by the HudsonAlpha Institute
for Biotechnology Genomic Services Laboratory (http://
www.hudsonalpha.org/gsl/). Transcriptome sequencing
was performed essentially as described by Mortazavi
et al. [88] in a modiﬁcation of the standard Illumina
methods described in detail in Bentley et al. [89].
Total RNA was reduced to poly-A+ RNA with oligo-
dT beads. Two rounds of poly-A+ selection were per-
formed. The puriﬁed mRNA was then subjected to
a mild heat fragmentation followed by random prim-
ing for ﬁrst-strand synthesis. Standard second-strand
synthesis was followed by standard library preparation
with the double-stranded cDNA as input material. This
approach is similar to that of Illumina’s TruSeq RNA-
seq library preparation kit. Sequencing was performed in
one lane on the Illumina HiSeq 2000 with 100-base-pair
paired-end reads.
Transcriptome assembly and analysis
The average insert length of our cDNA library was ∼170
nt, excluding the Illumina adaptors. With 100-base-pair
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Table 5 The 20most highly expressed nontoxin transcripts
Name Length % reads Function Accession
Protein disulﬁde isomerase 2970 5.223 Rearrange disulﬁde bonds (ER) JU175360
Cytochrome C oxidase subunit I 2789 0.966 Electron transport chain JU175042
Cytochrome B 1275 0.499 Electron transport chain JU175040
Translation elongation factor 1 α 1 1985 0.459 Translation JU174424
18S rRNA 2509 0.421 Ribosomal component JU173759
Calreticulin 1661 0.406 Protein chaperone (ER) JU174061
Endoplasmin (HSP90 family) 3012 0.333 Protein chaperone (ER) JU174456
78 kDa glucose-regulated protein 2676 0.332 Protein chaperone (ER) JU174713
Heat shock protein 5 (GRP78 splice variant?) 2063 0.327 Protein chaperone (ER) JU174801
NADH dehydrogenase subunit 5 4448 0.272 Electron transport chain JU175113
Cytochrome C oxidase subunit III 2103 0.239 Electron transport chain JU175043
Protein disulﬁde isomerase A6 4933 0.212 Rearrange disulﬁde bonds (ER) JU175358
Nucleobindin 2 2937 0.203 Calcium binding JU175278
Protein disulﬁde isomerase A3 1904 0.186 Rearrange disulﬁde bonds (ER) JU175355
NADH dehydrogenase subunit 1 1878 0.173 Electron transport chain JU175111
NADH dehydrogenase subunit 4 1751 0.172 Electron transport chain JU175112
Protein disulﬁde isomerase A4 2540 0.159 Rearrange disulﬁde bonds (ER) JU175356
Translation elongation factor 2 3057 0.147 Translation JU174429
Vigilin 2 6107 0.129 mRNA stability and translation JU176512
Actin, cytoplasmic 2 1971 0.124 Cytoskeleton JU173777
paired-end sequencing, the majority of paired-end reads
overlapped at their 3’ ends. Because read quality declines
toward the 3’ ends of reads, we developed a method
similar to that of Rodrigue et al. [36] for merging the
overlapping pairs into single, long, high-quality reads.
The members of each pair of reads were slid along
each other, and, for each overlap of length n, we cal-
culated the probability of getting the observed number












assuming any of the four nucleotides is equally likely to be
at any position. To be conservative, we only merged reads
Table 6 Toxin and protease inhibitors detected in the venom-gland transcripts
Name Length % reads Function Accession
Cystatin 1 790 9.80 × 10−4 Cysteine-protease inhibitor JU174278
Cystatin B 460 1.23 × 10−3 Cysteine-protease inhibitor JU174279
Cystatin 2 709 1.31 × 10−3 Cysteine-protease inhibitor JU174280
Metalloproteinase inhibitor 1 820 1.04 × 10−3 Metalloproteinase inhibitor JU175124
Metalloproteinase inhibitor 2 2560 2.57 × 10−3 Metalloproteinase inhibitor JU175125
Metalloproteinase inhibitor 3 2202 1.01 × 10−3 Metalloproteinase inhibitor JU175126
PLA2 inhibitor beta 1210 1.54 × 10−3 PLA2 inhibitor JU175425
PLA2 inhibitor gamma B 1 1492 3.68 × 10−3 PLA2 inhibitor JU175444
PLA2 inhibitor gamma B 2 1694 7.70 × 10−4 PLA2 inhibitor JU175442
PLA2 inhibitor B 2339 1.07 × 10−3 PLA2 inhibitor JU175443
Serpin B6 1708 9.68 × 10−3 Serine-proteinase inhibitor JU175869
Serpin H1 2004 9.40 × 10−4 Serine-proteinase inhibitor JU175870
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if the minimum probability was less than 10−10 and the
second smallest probability was at least 1000 times larger
(Figure 1A). The latter condition was meant to help avoid
merging reads that span highly repetitive regions. For
cases in which the insert size was less than the read length,
sequence data outside the overlap were assumed to repre-
sent adaptors and were deleted.We updated quality scores
for the overlapping positions following the approach of
Rodrigue et al. [36]. For merged reads, quality scores for
nonoverlapping bases were left unchanged (Figure 1B).
The unmerged reads were typically those pairs from the
longer end of the insert-size distribution.
Because of the inherent diﬃculty in de novo tran-
scriptome assembly, we used a diverse array of assembly
approaches and combined the results for a ﬁnal data
set. We performed assemblies using ABySS version 1.2.6
[37,38] under a wide array of parameter values using both
the merged and unmerged reads. In particular, we used
k-mer values of 51, 61, 71, 81, and 91 and varied the
coverage (c) and erode (e) parameters from 2 to 1,000.
We set E = 0, m = 20, and s = 200 for all assem-
blies. Trans-ABySS [90] provided little or no improvement
of our assemblies, primarily because assembly quality
appeared to be more dependent on the coverage and
erode parameters than on the k-mer length. We also con-
ducted assemblies using both the merged and unmerged
reads with Velvet version 1.1.02 [39] and k-mer values
of 71, 81, and 91. We selected the best of these assem-
blies on the basis of the N50 values for further assembly
into transcripts withOases version 0.1.20 (http://www.ebi.
ac.uk/∼zerbino/oases/) [40]. For Oases, we set the mini-
mum transcript length to 300 nt and the coverage cutoﬀ
to 10. We also followed the approach of Rokyta et al.
[11] and used the NGen2.2 assembler from DNAStar
(http://www.dnastar.com/). Because this assembler is lim-
ited to 20–30 million reads, we used only the merged
reads. We performed four independent assemblies: three
with 20 million merged reads each and one with the
remaining 12,114,709 merged reads. Each assembly was
performed with the default settings for high-stringency,
de novo transcriptome assembly for long Illumina reads,
including default quality trimming. The high-stringency
setting corresponded to setting the minimum match per-
centage to 90%. We retained contigs comprising at least
100 reads.
In addition to the all-at-once assembly approaches
above, we developed an iterative approach that was both
more eﬀective at generating full-length transcripts and
more computationally eﬃcient. The ﬁrst step consisted of
applying our Extender program (see below) as a de novo
assembler starting from 1,000 reads. Full-length tran-
scripts were identiﬁed with blastx searches (see below),
then used as templates in a reference-based assembly in
NGen3.1 with a 98% minimum match percentage to ﬁlter
reads corresponding to identiﬁed transcripts. Ten million
of the unassembled sequences were then used in a de
novo transcriptome assembly in NGen3.1 with the same
settings as described above for de novo assembly except
that theminimummatch percentage was increased to 93%
and contigs comprising less than 200 sequences were dis-
carded. The resulting sequences were identiﬁed, where
possible, by means of blastx searches, and the identiﬁed
full-length transcripts were used in another templated
assembly to generate a further-reduced set of reads. This
iterative process was repeated two additional times.
To provide transcriptional proﬁles of the venom gland,
we performed GO annotation with Blast2GO [73]. We
ran full analyses on one of NGen assemblies of 20 mil-
lion merged reads, including blastx searches, GO map-
ping, and annotation. We used the default Blast2GO
parameters throughout. We converted the GO anno-
tation to generic GO-slim terms. We ran the same
analysis on the combined set of annotated nontoxin
sequences.
For gene identiﬁcation and annotation, we conducted
blastx searches using mpiblast version 1.6.0 (http://www.
mpiblast.org/) of the consensus sequences of contigs of
our assemblies against the NCBI nonredundant pro-
tein database (nr; downloaded March 2011 and updated
through November 2011). We used an E-value cut-oﬀ of
10−4, and only the top 10 matches were considered. For
toxin identiﬁcation, hit descriptions were searched for
a set of keywords based on known snake-venom toxins
and protein classes. Any sequence matching these key-
words was checked for a full-length coding sequence. We
generally only retained transcripts with full-length cod-
ing sequences (but see below). For the iterative assembly
approach, the remaining, presumably nontoxin-encoding,
contigs were screened for those whose match lengths
were at least 90% of the length of at least one of their
database matches. This step was intended to minimize
the number of fragmented or partial sequences that were
considered for annotation. In addition, we sorted the
contigs of the three 20-million-sequence NGen assem-
blies from the all-at-once approach on the basis of the
number of reads and attempted to annotate the top 500
contigs from one assembly and the top 100 from the
other two.
We estimated transcript abundances using high-
stringency reference-based assemblies in NGen3.1 with
a minimum match percentage of 95. Ten million of the
merged reads were mapped onto the full-length, anno-
tated transcripts, and the percentage of reads mapping to
each transcript was used as a proxy for abundance.
The extender
The purpose of Extender is to estimate quickly one
or more full-length transcript sequences from a large
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number of high-quality sequence reads. The procedure
begins with one or more seed sequences provided by the
user. The seeds can be known sequences (e.g., partial
transcripts from a previous assembly) or simply sequences
of one or more of the reads. The Extender procedure
begins by hashing the k-mers observed at the two ends
of the seeds. If k is set to 50, for example, then the 50-
base sequence present at the 5’ end of each seed is used
as a key in a hash table, and the hash value is a pointer
to the seed in the list of seeds. A second hash table is
likewise used for k-mers from the 3’ ends of the seeds.
Note that this method requires that all initial k-mers be
unique (that no two sequence ends be identical). Once
the seeds are hashed, the seeds are extended with the
set of reads provided by the user as follows. The two k-
mers from the ends of each read are looked up in each
hash table. If the key is present in the hash table, the
seed is extended by concatenation of the nonoverlap-
ping bases from the read onto the appropriate end of the
seed. If the key is absent, the reverse complement of the
read is used to extend the seed if the end k-mers are
found. After each extension, the k-mer key facilitating the
extension is removed from the hash table and the new
k-mer key is added (the reference to the seed remains
the same). The procedure is repeated until the reads have
been cycled through N times, where N is chosen by the
user. Cycling is beneﬁcial because the Extender does not
reset to the beginning of the read list when an extension
is made.
Extension of a seed typically terminates when the end
of the full-length transcript is reached or when a sequenc-
ing error is encountered in the end of an incorporated
read. The presence of low-frequency biological artifacts
(e.g., unspliced introns) may also result in termination
of the extension. In order to improve the accuracy of
the consensus sequence prediction, Extender can cre-
ate replicate seeds for a particular seed by sequentially
trimming one base at a time from both ends. Using
replicate seeds allows several independent sequences that
represent the same target consensus sequence to be gen-
erated simultaneously, and these replicates are entirely
independent because they begin with diﬀerent keys. The
user can obtain the ﬁnal estimate of the sequence cor-
responding to each original seed by taking the consen-
sus across replicates or by simply choosing the replicate
producing the longest sequence. We took the former
approach for all of our assembly eﬀorts. Overall, Extender
is highly ineﬃcient with its use of data and requires many
long, high-quality reads, but it is extremely computation-
ally eﬃcient, having short run times and low memory
requirements.
We used Extender in two diﬀerent ways: to complete
partial toxin transcripts and as a de novo assembler. For
the former, we used partial toxin transcripts from NGen
assemblies that were found to have fragments of cod-
ing sequence homologous with known toxins. The par-
tial transcripts were trimmed to just the partial coding
sequence and used as seeds. To use Extender as a de novo
assembler, we seeded it with 1,000 random reads. For
both applications, we used a k-mer size of 100, 20 repli-
cates, 10 cycles through the complete set of merged reads
excluding all reads with any bases with quality scores less
than 30.
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